FDA Import Refusal 799-5820617-0/11/3 — GLENMARK PHARMACEUTICALS LTD
The FDA refused shipment 799-5820617-0/11/3 from GLENMARK PHARMACEUTICALS LTD (India) on February 26, 2025. The refused product falls under Drugs and Biologics — TELMISARTAN (ANTI-HYPERTENSIVE - PART II). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- February 26, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62OCY09 TELMISARTAN (ANTI-HYPERTENSIVE - PART II)
- Charges
- 118,75